Pentwater Capital Management LP Invests $9 Million in Surgery Partners, Inc. (NASDAQ:SGRY)

Pentwater Capital Management LP acquired a new stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 425,000 shares of the company's stock, valued at approximately $8,997,000. Pentwater Capital Management LP owned about 0.33% of Surgery Partners at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in SGRY. KBC Group NV increased its holdings in shares of Surgery Partners by 66.1% in the fourth quarter. KBC Group NV now owns 3,962 shares of the company's stock valued at $84,000 after purchasing an additional 1,577 shares during the period. MeadowBrook Investment Advisors LLC increased its holdings in Surgery Partners by 16.6% in the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company's stock worth $218,000 after buying an additional 1,460 shares during the period. Tower Research Capital LLC TRC increased its holdings in Surgery Partners by 279.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,762 shares of the company's stock worth $228,000 after buying an additional 7,925 shares during the period. Empowered Funds LLC purchased a new position in Surgery Partners during the 4th quarter worth approximately $245,000. Finally, KLP Kapitalforvaltning AS acquired a new stake in Surgery Partners during the 4th quarter valued at approximately $273,000.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Royal Bank of Canada reissued an "outperform" rating and set a $35.00 target price on shares of Surgery Partners in a report on Tuesday, March 25th. Macquarie reduced their price objective on Surgery Partners from $34.00 to $33.00 and set an "outperform" rating for the company in a research note on Tuesday, March 11th. Finally, Benchmark reaffirmed a "buy" rating and set a $35.00 target price on shares of Surgery Partners in a report on Monday, April 21st. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Surgery Partners presently has an average rating of "Moderate Buy" and an average target price of $34.75.

Surgery Partners Price Performance

Shares of Surgery Partners stock traded up $0.65 on Friday, reaching $23.08. The company's stock had a trading volume of 554,747 shares, compared to its average volume of 1,101,562. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.99. The company has a market capitalization of $2.96 billion, a P/E ratio of -48.08, a PEG ratio of 19.21 and a beta of 1.96. The stock has a 50-day moving average price of $22.75 and a 200-day moving average price of $23.74. Surgery Partners, Inc. has a 52-week low of $19.50 and a 52-week high of $33.97.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last posted its quarterly earnings data on Monday, March 3rd. The company reported $0.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.01. The company had revenue of $864.40 million for the quarter, compared to analysts' expectations of $828.09 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. Analysts expect that Surgery Partners, Inc. will post 0.67 EPS for the current year.

Insider Activity

In other Surgery Partners news, CFO David T. Doherty sold 13,641 shares of the business's stock in a transaction that occurred on Friday, February 7th. The shares were sold at an average price of $25.61, for a total transaction of $349,346.01. Following the completion of the transaction, the chief financial officer now owns 108,862 shares in the company, valued at $2,787,955.82. The trade was a 11.14 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Harrison R. Bane sold 56,315 shares of Surgery Partners stock in a transaction on Friday, February 7th. The stock was sold at an average price of $25.64, for a total transaction of $1,443,916.60. Following the sale, the insider now directly owns 107,037 shares of the company's stock, valued at approximately $2,744,428.68. This trade represents a 34.47 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 106,622 shares of company stock valued at $2,717,860. 2.30% of the stock is currently owned by company insiders.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.